Skip to content
PubMed This is a summary of 52 peer-reviewed journal articles Updated
Cardiology

Tropical endomyocardial fibrosis: A Patient Guide

At a Glance

Tropical endomyocardial fibrosis causes scar tissue inside the heart’s lower chambers, making them stiff and limiting how much blood the heart can hold. Echocardiography and cardiac MRI help assess the disease, while medicines manage symptoms and surgery may be considered in advanced cases.

Tropical endomyocardial fibrosis (EMF) is a rare and complex condition that changes the very structure of the heart. It is a type of restrictive cardiomyopathy, which means the heart muscle may initially remain strong enough to squeeze, but its pumping function can deteriorate over time, and it becomes too stiff to relax. This stiffness is caused by the progressive buildup of dense scar tissue, or fibrosis, inside the heart’s lower chambers (ventricles). As this lining thickens, it takes up space and prevents the heart from filling properly with blood, leading to a backup of pressure that often results in significant fluid retention in the abdomen and lungs [1][2].

While EMF is primarily seen in tropical regions of Sub-Saharan Africa, South Asia, and South America, its impact is felt most deeply by children and young adults, though it can affect people of all ages. The condition often progresses from an initial period of inflammation to a chronic stage where the permanent scarring dictates how the heart functions. Understanding the biology of this change is the first step toward managing its effects on your daily life [3][4].

Living with EMF requires a focused and specialized approach to care, starting with an accurate diagnosis. Because the scarring in EMF has a specific appearance, advanced imaging is an important complementary tool for your medical team. A specialized ultrasound called an echocardiogram and a Cardiac MRI can sometimes reveal the “double V” sign—a pattern of muscle, scar, and sometimes blood clots—that helps doctors confirm the diagnosis and assess the extent of the disease [5][6].

Managing the condition day-to-day usually involves an individualized combination of medications designed to ease the workload on the heart. While these treatments are “supportive”—meaning they help control symptoms like abdominal swelling (ascites) and protect against complications like blood clots or irregular rhythms—they do not remove the existing scar tissue. For those with advanced disease that no longer responds well to medication, surgery to physically remove the scar tissue and repair or replace heart valves may be considered. Although these procedures are high-risk, they offer the possibility of significantly improving how you feel and your ability to be active [7][8].

Navigating a diagnosis of EMF is a journey that requires patience and a dedicated multidisciplinary care team (including heart-failure cardiologists, imaging specialists, and cardiac surgeons). By combining modern imaging, careful fluid management, and a clear understanding of the surgical options, you and your doctors can work together to create a plan that prioritizes your comfort and long-term health [9][10].

How to Use This Guide

  • Decisions Are Individual: The symptoms, treatments, and timelines described here are general. Your specific care plan must be individualized based on your heart’s anatomy, your kidney function, and the goals that matter most to you.
  • Emergency Situations: Red-flag symptoms (such as sudden severe breathlessness, fainting, or signs of stroke) require immediate evaluation at a local emergency room, not a wait-and-see approach.

Common questions in this guide

What happens to the heart in tropical endomyocardial fibrosis?
Scar tissue gradually builds up along the inner lining of the heart’s lower chambers, called the ventricles. This makes the heart stiff and reduces its ability to fill, which can cause pressure and fluid to build up in the abdomen and lungs.
What tests are used to diagnose EMF?
Doctors commonly use an echocardiogram, a heart ultrasound, and cardiac MRI to examine the heart’s shape, scar tissue, and possible clots. These tests may show a characteristic “double V” pattern that supports the diagnosis and helps measure how much of the heart is affected.
Can medicines remove the scar tissue caused by EMF?
Medicines can ease the heart’s workload, help control fluid buildup such as ascites, and reduce the risk of complications such as blood clots or irregular rhythms. They are supportive treatments and do not remove scar tissue that is already present.
When might surgery be considered for tropical endomyocardial fibrosis?
Surgery may be considered when the disease is advanced and symptoms or heart problems are not controlled well enough with medication. The procedure may remove scar tissue and repair or replace damaged heart valves; it is high risk, so decisions should be made with an experienced multidisciplinary team.
What symptoms mean I should seek emergency help with EMF?
Sudden severe breathlessness, fainting, or signs of a stroke require immediate evaluation in a local emergency room. Do not wait to see whether these symptoms improve at home.

Get notified when new evidence is published on Tropical endomyocardial fibrosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (10)
  1. 1

    Tropical Endomyocardial Fibrosis: Natural History, Challenges, and Perspectives.

    Grimaldi A, Mocumbi AO, Freers J, et al.

    Circulation 2016; (133(24)):2503-15 doi:10.1161/CIRCULATIONAHA.115.021178.

    PMID: 27297343
  2. 2

    Left ventricle endomyocardial fibrosis: a case report.

    Soares RR, Avelar MCM, Zanetti SL, et al.

    Journal of medical case reports 2023; (17(1)):361 doi:10.1186/s13256-023-04056-z.

    PMID: 37568222
  3. 3

    Comprehensive Assessment of Endomyocardial Fibrosis with Cardiac MRI: Morphology, Function, and Tissue Characterization.

    de Carvalho FP, Azevedo CF

    Radiographics : a review publication of the Radiological Society of North America, Inc 2020; (40(2)):336-353 doi:10.1148/rg.2020190148.

    PMID: 32004118
  4. 4

    [Endomyocardial fibrosis in Cameroon: Echocardiographic and clinical description of a pediatric series in Yaoundé].

    Chelo D, Nguefack F, Menanga AP, et al.

    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie 2016; (23(2)):128-35.

    PMID: 26724978
  5. 5

    An Unusual Cause of Unstable Angina: Endomyocardial Fibrosis.

    Tapia Martínez M, Velasco EB, Romano M, et al.

    European journal of case reports in internal medicine 2025; (12(12)):005878 doi:10.12890/2025_005878.

    PMID: 41377797
  6. 6

    Application of Routine Echocardiography Combined with Contrast-Enhanced Echocardiography in the Diagnosis of Endomyocardial Fibrosis.

    Wu B, Yang Y, Zhao P

    Discovery medicine 2023; (35(179)):1052-1063 doi:10.24976/Discov.Med.202335179.101.

    PMID: 38058070
  7. 7

    Where is the right ventricle? Accurate diagnosis with cardiovascular multimodality imaging.

    Güner A, Topel Ç, Cansever AT, et al.

    Echocardiography (Mount Kisco, N.Y.) 2020; (37(3)):456-461 doi:10.1111/echo.14606.

    PMID: 32045035
  8. 8

    Cardiac surgery in Africa: a thirty-five year experience on open heart surgery in Cote d'Ivoire.

    Yangni-Angate KH, Meneas C, Diby F, et al.

    Cardiovascular diagnosis and therapy 2016; (6(Suppl 1)):S44-S63 doi:10.21037/cdt.2016.10.06.

    PMID: 27904843
  9. 9

    Endomyocardial fibrosis in adults: multimodality imaging phenotype and independent predictors of mortality.

    Hotta VT, Romero CE, Madrini V, et al.

    International journal of cardiology 2026; 134929 doi:10.1016/j.ijcard.2026.134929.

    PMID: 42790752
  10. 10

    Exercise Rehabilitation Improves Cardiac Volumes and Functional Capacity in Patients With Endomyocardial Fibrosis: A RANDOMIZED CONTROLLED TRIAL.

    Sayegh ALC, Dos Santos MR, Rondon E, et al.

    Journal of cardiopulmonary rehabilitation and prevention 2019; (39(6)):373-380 doi:10.1097/HCR.0000000000000445.

    PMID: 31397769

This guide about tropical endomyocardial fibrosis is for informational purposes only and does not constitute medical advice. Discuss your imaging, medications, and any surgical options with your cardiology team.